APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topical Retinoids

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Topical Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025199 pages

Choose your research edition.

Industry ResearchTopical Retinoids Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Topical Retinoids Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Topical Retinoids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topical Retinoids Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Topical Retinoids Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Topical Retinoids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Topical Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Topical Retinoids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Retinoids include Chongqing Huapont Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Shanghai Sine Pharmaceutical, Shanghai Shyndec Pharmaceutical, Kangzheng pharmaceutical, Hubei Hengan Fulin Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Topical Retinoids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Retinoids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Retinoids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Retinoids market size, projected growth trends, production technologies, key applications, and end-use industries.

Topical Retinoids Segment by Company

Chongqing Huapont Pharmaceutical

Sichuan Med-Shine Pharmaceutical

Shanghai Sine Pharmaceutical

Shanghai Shyndec Pharmaceutical

Kangzheng pharmaceutical

Hubei Hengan Fulin Pharmaceutical

Heilongjiang Fuhe Pharmaceutical

HEC Pharm

Teva

Taro Pharmaceutical

Sandoz

Padagis

Ligand Pharmaceuticals

Hikma

Galderma Laboratories

Eisai

Dr. Reddy's Laboratories

Bionpharma

Bausch Health

Amneal Pharmaceuticals

Amdipharm

Allergan

Alembic

Actavis

Topical Retinoids Segment by Type

Gel

Cream

Lotion

Others

Topical Retinoids Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Topical Retinoids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Retinoids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Retinoids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Retinoids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Topical Retinoids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Topical Retinoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Topical Retinoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Topical Retinoids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Topical Retinoids Industry Trends Table 2. Topical Retinoids Industry Drivers Table 3. Topical Retinoids Industry Opportunities and Challenges Table 4. Topical Retinoids Industry Restraints Table 5. Global Topical Retinoids Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Topical Retinoids Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Topical Retinoids Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Topical Retinoids Sales Market Share by Manufacturers Table 9. Global Topical Retinoids Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Topical Retinoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Topical Retinoids Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Topical Retinoids Manufacturers, Product Type & Application Table 13. Global Topical Retinoids Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Topical Retinoids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Gel Table 17. Major Manufacturers of Cream Table 18. Major Manufacturers of Lotion Table 19. Major Manufacturers of Others Table 20. Global Topical Retinoids Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Topical Retinoids Sales by Type (2021-2026) & (K Units) Table 22. Global Topical Retinoids Sales by Type (2027-2032) & (K Units) Table 23. Global Topical Retinoids Sales Market Share by Type (2021-2026) Table 24. Global Topical Retinoids Sales Market Share by Type (2027-2032) Table 25. Global Topical Retinoids Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Topical Retinoids Revenue by Type (2021-2026) & (K Units) Table 27. Global Topical Retinoids Revenue by Type (2027-2032) & (K Units) Table 28. Global Topical Retinoids Revenue Market Share by Type (2021-2026) Table 29. Global Topical Retinoids Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Retail Pharmacy Table 31. Major Manufacturers of Online Pharmacy Table 32. Major Manufacturers of Hospital Pharmacy Table 33. Global Topical Retinoids Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Topical Retinoids Sales by Application (2021-2026) & (K Units) Table 35. Global Topical Retinoids Sales by Application (2027-2032) & (K Units) Table 36. Global Topical Retinoids Sales Market Share by Application (2021-2026) Table 37. Global Topical Retinoids Sales Market Share by Application (2027-2032) Table 38. Global Topical Retinoids Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Topical Retinoids Revenue by Application (2021-2026) & (K Units) Table 40. Global Topical Retinoids Revenue by Application (2027-2032) & (K Units) Table 41. Global Topical Retinoids Revenue Market Share by Application (2021-2026) Table 42. Global Topical Retinoids Revenue Market Share by Application (2027-2032) Table 43. Global Topical Retinoids Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Topical Retinoids Sales by Region (2021-2026) & (K Units) Table 45. Global Topical Retinoids Sales Market Share by Region (2021-2026) Table 46. Global Topical Retinoids Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Topical Retinoids Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 50. North America Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 51. Europe Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 53. Europe Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Topical Retinoids Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Topical Retinoids Sales by Country (2027-2032) & (K Units) Table 60. Global Topical Retinoids Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Topical Retinoids Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Topical Retinoids Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Topical Retinoids Revenue Market Share by Region (2021-2026) Table 64. Global Topical Retinoids Revenue Market Share by Region (2027-2032) Table 65. Chongqing Huapont Pharmaceutical Company Information Table 66. Chongqing Huapont Pharmaceutical Business Overview Table 67. Chongqing Huapont Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chongqing Huapont Pharmaceutical Topical Retinoids Product Portfolio Table 69. Chongqing Huapont Pharmaceutical Recent Development Table 70. Sichuan Med-Shine Pharmaceutical Company Information Table 71. Sichuan Med-Shine Pharmaceutical Business Overview Table 72. Sichuan Med-Shine Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sichuan Med-Shine Pharmaceutical Topical Retinoids Product Portfolio Table 74. Sichuan Med-Shine Pharmaceutical Recent Development Table 75. Shanghai Sine Pharmaceutical Company Information Table 76. Shanghai Sine Pharmaceutical Business Overview Table 77. Shanghai Sine Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Shanghai Sine Pharmaceutical Topical Retinoids Product Portfolio Table 79. Shanghai Sine Pharmaceutical Recent Development Table 80. Shanghai Shyndec Pharmaceutical Company Information Table 81. Shanghai Shyndec Pharmaceutical Business Overview Table 82. Shanghai Shyndec Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Shanghai Shyndec Pharmaceutical Topical Retinoids Product Portfolio Table 84. Shanghai Shyndec Pharmaceutical Recent Development Table 85. Kangzheng pharmaceutical Company Information Table 86. Kangzheng pharmaceutical Business Overview Table 87. Kangzheng pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Kangzheng pharmaceutical Topical Retinoids Product Portfolio Table 89. Kangzheng pharmaceutical Recent Development Table 90. Hubei Hengan Fulin Pharmaceutical Company Information Table 91. Hubei Hengan Fulin Pharmaceutical Business Overview Table 92. Hubei Hengan Fulin Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Hubei Hengan Fulin Pharmaceutical Topical Retinoids Product Portfolio Table 94. Hubei Hengan Fulin Pharmaceutical Recent Development Table 95. Heilongjiang Fuhe Pharmaceutical Company Information Table 96. Heilongjiang Fuhe Pharmaceutical Business Overview Table 97. Heilongjiang Fuhe Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Heilongjiang Fuhe Pharmaceutical Topical Retinoids Product Portfolio Table 99. Heilongjiang Fuhe Pharmaceutical Recent Development Table 100. HEC Pharm Company Information Table 101. HEC Pharm Business Overview Table 102. HEC Pharm Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. HEC Pharm Topical Retinoids Product Portfolio Table 104. HEC Pharm Recent Development Table 105. Teva Company Information Table 106. Teva Business Overview Table 107. Teva Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Teva Topical Retinoids Product Portfolio Table 109. Teva Recent Development Table 110. Taro Pharmaceutical Company Information Table 111. Taro Pharmaceutical Business Overview Table 112. Taro Pharmaceutical Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Taro Pharmaceutical Topical Retinoids Product Portfolio Table 114. Taro Pharmaceutical Recent Development Table 115. Sandoz Company Information Table 116. Sandoz Business Overview Table 117. Sandoz Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Sandoz Topical Retinoids Product Portfolio Table 119. Sandoz Recent Development Table 120. Padagis Company Information Table 121. Padagis Business Overview Table 122. Padagis Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Padagis Topical Retinoids Product Portfolio Table 124. Padagis Recent Development Table 125. Ligand Pharmaceuticals Company Information Table 126. Ligand Pharmaceuticals Business Overview Table 127. Ligand Pharmaceuticals Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Ligand Pharmaceuticals Topical Retinoids Product Portfolio Table 129. Ligand Pharmaceuticals Recent Development Table 130. Hikma Company Information Table 131. Hikma Business Overview Table 132. Hikma Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Hikma Topical Retinoids Product Portfolio Table 134. Hikma Recent Development Table 135. Galderma Laboratories Company Information Table 136. Galderma Laboratories Business Overview Table 137. Galderma Laboratories Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Galderma Laboratories Topical Retinoids Product Portfolio Table 139. Galderma Laboratories Recent Development Table 140. Eisai Company Information Table 141. Eisai Business Overview Table 142. Eisai Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Eisai Topical Retinoids Product Portfolio Table 144. Eisai Recent Development Table 145. Dr. Reddy's Laboratories Company Information Table 146. Dr. Reddy's Laboratories Business Overview Table 147. Dr. Reddy's Laboratories Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Dr. Reddy's Laboratories Topical Retinoids Product Portfolio Table 149. Dr. Reddy's Laboratories Recent Development Table 150. Bionpharma Company Information Table 151. Bionpharma Business Overview Table 152. Bionpharma Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Bionpharma Topical Retinoids Product Portfolio Table 154. Bionpharma Recent Development Table 155. Bausch Health Company Information Table 156. Bausch Health Business Overview Table 157. Bausch Health Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Bausch Health Topical Retinoids Product Portfolio Table 159. Bausch Health Recent Development Table 160. Amneal Pharmaceuticals Company Information Table 161. Amneal Pharmaceuticals Business Overview Table 162. Amneal Pharmaceuticals Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Amneal Pharmaceuticals Topical Retinoids Product Portfolio Table 164. Amneal Pharmaceuticals Recent Development Table 165. Amdipharm Company Information Table 166. Amdipharm Business Overview Table 167. Amdipharm Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Amdipharm Topical Retinoids Product Portfolio Table 169. Amdipharm Recent Development Table 170. Allergan Company Information Table 171. Allergan Business Overview Table 172. Allergan Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Allergan Topical Retinoids Product Portfolio Table 174. Allergan Recent Development Table 175. Alembic Company Information Table 176. Alembic Business Overview Table 177. Alembic Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 178. Alembic Topical Retinoids Product Portfolio Table 179. Alembic Recent Development Table 180. Actavis Company Information Table 181. Actavis Business Overview Table 182. Actavis Topical Retinoids Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 183. Actavis Topical Retinoids Product Portfolio Table 184. Actavis Recent Development Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Topical Retinoids Distributors List Table 188. Topical Retinoids Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Topical Retinoids Product Image Figure 2. Global Topical Retinoids Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Retinoids Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Retinoids Sales (2021-2032) & (K Units) Figure 5. Global Topical Retinoids Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Topical Retinoids Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Gel Image Figure 9. Cream Image Figure 10. Lotion Image Figure 11. Others Image Figure 12. Global Topical Retinoids Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Topical Retinoids Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Topical Retinoids Sales Market Share by Type (2021-2032) Figure 15. Global Topical Retinoids Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Topical Retinoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Topical Retinoids Revenue Market Share by Type (2021-2032) Figure 18. Retail Pharmacy Image Figure 19. Online Pharmacy Image Figure 20. Hospital Pharmacy Image Figure 21. Global Topical Retinoids Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Topical Retinoids Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Topical Retinoids Sales Market Share by Application (2021-2032) Figure 24. Global Topical Retinoids Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Topical Retinoids Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Topical Retinoids Revenue Market Share by Application (2021-2032) Figure 27. North America Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Topical Retinoids Sales Market Share by Country (2021-2032) Figure 29. U.S. Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Topical Retinoids Sales Market Share by Country (2021-2032) Figure 34. Germany Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Topical Retinoids Sales Market Share by Country (2021-2032) Figure 41. China Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Topical Retinoids Sales Market Share by Country (2021-2032) Figure 49. Brazil Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Topical Retinoids Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Topical Retinoids Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Topical Retinoids Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Topical Retinoids Revenue (2021-2032) & (US$ Million) Figure 60. North America Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Topical Retinoids Revenue (2021-2032) & (US$ Million) Figure 62. Europe Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Topical Retinoids Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Topical Retinoids Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Topical Retinoids Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Topical Retinoids Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Cream
  • Lotion
  • Others
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Chongqing Huapont Pharmaceutical
  • Sichuan Med-Shine Pharmaceutical
  • Shanghai Sine Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Kangzheng pharmaceutical
  • Hubei Hengan Fulin Pharmaceutical
  • Heilongjiang Fuhe Pharmaceutical
  • HEC Pharm
  • Teva
  • Taro Pharmaceutical
  • Sandoz
  • Padagis
  • Ligand Pharmaceuticals
  • Hikma
  • Galderma Laboratories
  • Eisai
  • Dr. Reddy's Laboratories
  • Bionpharma
  • Bausch Health
  • Amneal Pharmaceuticals
  • Amdipharm
  • Allergan
  • Alembic
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Topical Retinoids Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Topical Retinoids Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Topical Retinoids Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Topical Retinoids Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Topical Retinoids Market Dynamics
  1. 2.1 Topical Retinoids Industry Trends
  2. 2.2 Topical Retinoids Industry Drivers
  3. 2.3 Topical Retinoids Industry Opportunities and Challenges
  4. 2.4 Topical Retinoids Industry Restraints
3 Topical Retinoids Market by Manufacturers
  1. 3.1 Global Topical Retinoids Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Topical Retinoids Sales by Manufacturers (2021-2026)
  3. 3.3 Global Topical Retinoids Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Topical Retinoids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Topical Retinoids Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Topical Retinoids Manufacturers, Product Type & Application
  7. 3.7 Global Topical Retinoids Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Topical Retinoids Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Topical Retinoids Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Topical Retinoids Tier 1, Tier 2, and Tier 3
4 Topical Retinoids Market by Type
  1. 4.1 Topical Retinoids Type Introduction
  2. 4.1.1 Gel
  3. 4.1.2 Cream
  4. 4.1.3 Lotion
  5. 4.1.4 Others
  6. 4.2 Global Topical Retinoids Sales by Type
  7. 4.2.1 Global Topical Retinoids Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Topical Retinoids Sales by Type (2021-2032)
  9. 4.2.3 Global Topical Retinoids Sales Market Share by Type (2021-2032)
  10. 4.3 Global Topical Retinoids Revenue by Type
  11. 4.3.1 Global Topical Retinoids Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Topical Retinoids Revenue by Type (2021-2032)
  13. 4.3.3 Global Topical Retinoids Revenue Market Share by Type (2021-2032)
5 Topical Retinoids Market by Application
  1. 5.1 Topical Retinoids Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Topical Retinoids Sales by Application
  6. 5.2.1 Global Topical Retinoids Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Topical Retinoids Sales by Application (2021-2032)
  8. 5.2.3 Global Topical Retinoids Sales Market Share by Application (2021-2032)
  9. 5.3 Global Topical Retinoids Revenue by Application
  10. 5.3.1 Global Topical Retinoids Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Topical Retinoids Revenue by Application (2021-2032)
  12. 5.3.3 Global Topical Retinoids Revenue Market Share by Application (2021-2032)
6 Global Topical Retinoids Sales by Region
  1. 6.1 Global Topical Retinoids Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Topical Retinoids Sales by Region (2021-2032)
  3. 6.2.1 Global Topical Retinoids Sales by Region (2021-2026)
  4. 6.2.2 Global Topical Retinoids Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Topical Retinoids Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Topical Retinoids Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Topical Retinoids Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Topical Retinoids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Topical Retinoids Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Topical Retinoids Revenue by Region
  1. 7.1 Global Topical Retinoids Revenue by Region
  2. 7.1.1 Global Topical Retinoids Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Topical Retinoids Revenue by Region (2021-2026)
  4. 7.1.3 Global Topical Retinoids Revenue by Region (2027-2032)
  5. 7.1.4 Global Topical Retinoids Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Topical Retinoids Revenue (2021-2032)
  8. 7.2.2 North America Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Topical Retinoids Revenue (2021-2032)
  11. 7.3.2 Europe Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Topical Retinoids Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Topical Retinoids Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Topical Retinoids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Huapont Pharmaceutical
  2. 8.1.1 Chongqing Huapont Pharmaceutical Company Information
  3. 8.1.2 Chongqing Huapont Pharmaceutical Business Overview
  4. 8.1.3 Chongqing Huapont Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Huapont Pharmaceutical Topical Retinoids Product Portfolio
  6. 8.1.5 Chongqing Huapont Pharmaceutical Recent Developments
  7. 8.2 Sichuan Med-Shine Pharmaceutical
  8. 8.2.1 Sichuan Med-Shine Pharmaceutical Company Information
  9. 8.2.2 Sichuan Med-Shine Pharmaceutical Business Overview
  10. 8.2.3 Sichuan Med-Shine Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sichuan Med-Shine Pharmaceutical Topical Retinoids Product Portfolio
  12. 8.2.5 Sichuan Med-Shine Pharmaceutical Recent Developments
  13. 8.3 Shanghai Sine Pharmaceutical
  14. 8.3.1 Shanghai Sine Pharmaceutical Company Information
  15. 8.3.2 Shanghai Sine Pharmaceutical Business Overview
  16. 8.3.3 Shanghai Sine Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shanghai Sine Pharmaceutical Topical Retinoids Product Portfolio
  18. 8.3.5 Shanghai Sine Pharmaceutical Recent Developments
  19. 8.4 Shanghai Shyndec Pharmaceutical
  20. 8.4.1 Shanghai Shyndec Pharmaceutical Company Information
  21. 8.4.2 Shanghai Shyndec Pharmaceutical Business Overview
  22. 8.4.3 Shanghai Shyndec Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Shyndec Pharmaceutical Topical Retinoids Product Portfolio
  24. 8.4.5 Shanghai Shyndec Pharmaceutical Recent Developments
  25. 8.5 Kangzheng pharmaceutical
  26. 8.5.1 Kangzheng pharmaceutical Company Information
  27. 8.5.2 Kangzheng pharmaceutical Business Overview
  28. 8.5.3 Kangzheng pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kangzheng pharmaceutical Topical Retinoids Product Portfolio
  30. 8.5.5 Kangzheng pharmaceutical Recent Developments
  31. 8.6 Hubei Hengan Fulin Pharmaceutical
  32. 8.6.1 Hubei Hengan Fulin Pharmaceutical Company Information
  33. 8.6.2 Hubei Hengan Fulin Pharmaceutical Business Overview
  34. 8.6.3 Hubei Hengan Fulin Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hubei Hengan Fulin Pharmaceutical Topical Retinoids Product Portfolio
  36. 8.6.5 Hubei Hengan Fulin Pharmaceutical Recent Developments
  37. 8.7 Heilongjiang Fuhe Pharmaceutical
  38. 8.7.1 Heilongjiang Fuhe Pharmaceutical Company Information
  39. 8.7.2 Heilongjiang Fuhe Pharmaceutical Business Overview
  40. 8.7.3 Heilongjiang Fuhe Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Heilongjiang Fuhe Pharmaceutical Topical Retinoids Product Portfolio
  42. 8.7.5 Heilongjiang Fuhe Pharmaceutical Recent Developments
  43. 8.8 HEC Pharm
  44. 8.8.1 HEC Pharm Company Information
  45. 8.8.2 HEC Pharm Business Overview
  46. 8.8.3 HEC Pharm Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 HEC Pharm Topical Retinoids Product Portfolio
  48. 8.8.5 HEC Pharm Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Topical Retinoids Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Taro Pharmaceutical
  56. 8.10.1 Taro Pharmaceutical Company Information
  57. 8.10.2 Taro Pharmaceutical Business Overview
  58. 8.10.3 Taro Pharmaceutical Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Taro Pharmaceutical Topical Retinoids Product Portfolio
  60. 8.10.5 Taro Pharmaceutical Recent Developments
  61. 8.11 Sandoz
  62. 8.11.1 Sandoz Company Information
  63. 8.11.2 Sandoz Business Overview
  64. 8.11.3 Sandoz Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sandoz Topical Retinoids Product Portfolio
  66. 8.11.5 Sandoz Recent Developments
  67. 8.12 Padagis
  68. 8.12.1 Padagis Company Information
  69. 8.12.2 Padagis Business Overview
  70. 8.12.3 Padagis Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Padagis Topical Retinoids Product Portfolio
  72. 8.12.5 Padagis Recent Developments
  73. 8.13 Ligand Pharmaceuticals
  74. 8.13.1 Ligand Pharmaceuticals Company Information
  75. 8.13.2 Ligand Pharmaceuticals Business Overview
  76. 8.13.3 Ligand Pharmaceuticals Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ligand Pharmaceuticals Topical Retinoids Product Portfolio
  78. 8.13.5 Ligand Pharmaceuticals Recent Developments
  79. 8.14 Hikma
  80. 8.14.1 Hikma Company Information
  81. 8.14.2 Hikma Business Overview
  82. 8.14.3 Hikma Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hikma Topical Retinoids Product Portfolio
  84. 8.14.5 Hikma Recent Developments
  85. 8.15 Galderma Laboratories
  86. 8.15.1 Galderma Laboratories Company Information
  87. 8.15.2 Galderma Laboratories Business Overview
  88. 8.15.3 Galderma Laboratories Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Galderma Laboratories Topical Retinoids Product Portfolio
  90. 8.15.5 Galderma Laboratories Recent Developments
  91. 8.16 Eisai
  92. 8.16.1 Eisai Company Information
  93. 8.16.2 Eisai Business Overview
  94. 8.16.3 Eisai Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Eisai Topical Retinoids Product Portfolio
  96. 8.16.5 Eisai Recent Developments
  97. 8.17 Dr. Reddy's Laboratories
  98. 8.17.1 Dr. Reddy's Laboratories Company Information
  99. 8.17.2 Dr. Reddy's Laboratories Business Overview
  100. 8.17.3 Dr. Reddy's Laboratories Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy's Laboratories Topical Retinoids Product Portfolio
  102. 8.17.5 Dr. Reddy's Laboratories Recent Developments
  103. 8.18 Bionpharma
  104. 8.18.1 Bionpharma Company Information
  105. 8.18.2 Bionpharma Business Overview
  106. 8.18.3 Bionpharma Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bionpharma Topical Retinoids Product Portfolio
  108. 8.18.5 Bionpharma Recent Developments
  109. 8.19 Bausch Health
  110. 8.19.1 Bausch Health Company Information
  111. 8.19.2 Bausch Health Business Overview
  112. 8.19.3 Bausch Health Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Bausch Health Topical Retinoids Product Portfolio
  114. 8.19.5 Bausch Health Recent Developments
  115. 8.20 Amneal Pharmaceuticals
  116. 8.20.1 Amneal Pharmaceuticals Company Information
  117. 8.20.2 Amneal Pharmaceuticals Business Overview
  118. 8.20.3 Amneal Pharmaceuticals Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals Topical Retinoids Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals Recent Developments
  121. 8.21 Amdipharm
  122. 8.21.1 Amdipharm Company Information
  123. 8.21.2 Amdipharm Business Overview
  124. 8.21.3 Amdipharm Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Amdipharm Topical Retinoids Product Portfolio
  126. 8.21.5 Amdipharm Recent Developments
  127. 8.22 Allergan
  128. 8.22.1 Allergan Company Information
  129. 8.22.2 Allergan Business Overview
  130. 8.22.3 Allergan Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Allergan Topical Retinoids Product Portfolio
  132. 8.22.5 Allergan Recent Developments
  133. 8.23 Alembic
  134. 8.23.1 Alembic Company Information
  135. 8.23.2 Alembic Business Overview
  136. 8.23.3 Alembic Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Alembic Topical Retinoids Product Portfolio
  138. 8.23.5 Alembic Recent Developments
  139. 8.24 Actavis
  140. 8.24.1 Actavis Company Information
  141. 8.24.2 Actavis Business Overview
  142. 8.24.3 Actavis Topical Retinoids Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Actavis Topical Retinoids Product Portfolio
  144. 8.24.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Topical Retinoids Value Chain Analysis
  2. 9.1.1 Topical Retinoids Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Topical Retinoids Production Mode & Process
  6. 9.2 Topical Retinoids Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Topical Retinoids Distributors
  9. 9.2.3 Topical Retinoids Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst